Clinical Trial Update: Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating teriparatide injections to prevent hypocalcemia after parathyroidectomy in dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-mineral and Bone Disorder
• Hyperparathyroidism
• Hypocalcemia

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Saint Petersburg State University, Russia | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder | Phase 3 | Status: COMPLETED